


All 50 States Reach $7.4 Billion Settlement with Purdue Pharma Over Opioid Crisis
All 50 U.S. states have agreed to a $7.4 billion settlement with Purdue Pharma to address the opioid crisis, funding addiction treatment and prevention programs.
Overview
A summary of the key points of this story verified across multiple sources.
- All 50 U.S. states, Washington, D.C., and four territories have agreed to a $7.4 billion settlement with Purdue Pharma over opioid-related lawsuits.
- The Sackler family, owners of Purdue Pharma, will contribute up to $7 billion over 15 years as part of the settlement agreement.
- A judge is being requested to advance the settlement to allow local governments and victims to vote on it after state support.
- The settlement aims to allocate funds to state and local governments to combat the addiction and overdose crisis in the U.S.
- This settlement represents one of the largest in a decade, reflecting a unified effort to address the opioid epidemic.
Content generated by AI—learn more or report issue.

Get both sides in 5 minutes with our daily newsletter.
Analysis
Compare how each side frames the story — including which facts they emphasize or leave out.
Emphasizes all 50 U.S. states' support for Purdue Pharma's $7 billion opioid settlement plan.
Articles (6)
Compare how different news outlets are covering this story.
LeftCenterRight






FAQ
Dig deeper on this story with frequently asked questions.
The Sackler family will pay $1.5 billion, and Purdue Pharma will pay approximately $900 million in the first year.
The funds will be allocated to support addiction treatment, prevention, and recovery services across the U.S.
This settlement is one of the largest efforts to address the opioid epidemic, marking a unified endeavor to combat addiction and overdose across the U.S.
History
See how this story has evolved over time.
- 7d6 articles
- 8d3 articles